Fig. 1From: Caveat emptor: the combined effects of multiplicity and selective reportingResults of the resampling meta-analyses for pain intensity at 8 weeks [18]. CSR Clinical Study Report, FDA U.S. Food and Drug Administration, IPD Individual patient data, SMD Standardized mean differenceBack to article page